Pancreatic Cancer Research

ResearcherKing Abdulaziz UniversityNo recent work listed

Nabil A. Alhakamy

ORCID-verified (high confidence, 0.95), identity_conf@1As of 9 November 2026

Matched on ORCID iD 0000-0002-3826-1519; OpenAlex author ID A5014649653. Sources: OpenAlex.

Their work

Papers
5
Trials
0
Grants
0
Labs led
0
Collaborators
3
Papers, trials and grants by year

2021: 2 papers · 2022: 2 papers · 2023: 1 paper

Papers 5

  1. Retraction Note: Development and Evaluation of Icariin-Loaded PLGA-PEG Nanoparticles for Potentiation the Proapoptotic Activity in Pancreatic Cancer Cells. Co-author DOI 10.1208/s12249-023-02614-8↗
  2. Potentiality of raloxifene loaded melittin functionalized lipidic nanovesicles against pancreatic cancer cells. Co-author DOI 10.1080/10717544.2022.2072544↗
  3. Conjugation of bisphosphonates with scorpion venom enhanced apoptotic activities in pancreatic cancer cells Co-author DOI 10.1101/2022.08.30.505790↗
  4. Development and Evaluation of Icariin-Loaded PLGA-PEG Nanoparticles for Potentiation the Proapoptotic Activity in Pancreatic Cancer Cells. Co-author DOI 10.1208/s12249-021-02111-w↗
  5. Apamin-Conjugated Alendronate Sodium Nanocomplex for Management of Pancreatic Cancer. Co-author DOI 10.3390/ph14080729↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Usama Ahmed Fahmy · 3 shared papers, 2021–2022 · strength 0.53
  2. Shadab Md · 1 shared paper, 2021 · strength 0.19
  3. Walaa A. Abualsunun · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.